In February, BASF announced the divestment of its animal nutrition premix business selling facilities in eight countries. This sale covered the majority of BASF’s premix business.
“BASF continues to implement its business strategy and is
closing these North American sites, in order to focus on our core strategic
position and strength as an ingredient supplier to the animal nutrition
industry,” said Simon Medley, group vice president, Fine Chemicals. “BASF wants
to strengthen its role as a reliable and quality-focused ingredient supplier,
while exiting the premix arena.” BASF is closing these sites as part of the
continuing effort to focus on producing and marketing important vitamins,
carotenoids, enzymes and organic acids to the nutrition
2/3 articles remaining | Register to continue reading.